Faeth Therapeutics
Faeth Therapeutics develops PIKTOR, an oral combination of PI3K and mTOR inhibitors, in clinical-stage testing for endometrial and breast cancer through multi-pathway inhibition.
8-KSep 17Latest SEC filing, period to Sep 11
Sep 17Latest story